Sahm Adrangi is Still Following Fundamental Investing In a Bull Market

Even though the stock market has been following bullish trends for several years, Sahm Adrangi and his team at Kerrisdale Capital believe that fundamental investing is still a good way to go with proper research and analysis. Sahm Adrangi states that they have not had a lot of difficulties while picking good stocks for long-term investing while also shorting stocks that he sees as headed towards a downward trend. Despite some rather mechanical approaches that many investors have been following as of late, Kerrisdale is still sticking with the methods that have worked for them in the past.

Currently, Kerrisdale and Sahm Adrangi have shown an interest in shorting the stocks of the pharmaceutical research company Proteostasis. The Phase 2 data for one of their drugs that are still in the research and testing phases does not appear to be everything that the company is promising according to the investment firm. This is why they have chosen to take a short position on the stock as they believe that the4 gains that the company has experienced lately will surely reverse themselves quickly once the truth of the drug comes out to the public.

Additionally, the company has presented research and evidence that indicates that the land development company St. Joe’s is not going to be able to deliver on the promises that they have made to their investors concerning a large area of land in Florida. While St. Joe’s may have seen a decent amount of success while developing beachfront land, the land that is in question is almost entirely swampland and is not in a convenient location to the many attractions that draw people to the state of Florida. Their shareholders have been waiting patiently for years according to Sahm Adrangi, but he doesn’t believe that any amount of waiting will allow them to see a significant return on their investments as they had been promised by the company. When releasing their short stances on companies, Sahm Adrangi and Kerrisdale Capital have extensive research to back up their claims. They have absolutely no problem releasing it to the public as they have in the past.

http://fortune.com/2016/04/21/sahm-adrangi-kerrisdale-short-sale/